Skip to content
10-Q

Quarterly Report

Quipt Home Medical Corp.

0001558370-25-007420

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · May 9, 2025 43.44M sh
Shares Diluted Q2 2025 · Mar 31, 2025 43.17K sh
Shares Diluted Q2 2025 · Mar 31, 2025 43.13K sh
Shares Diluted Q2 2025 · Mar 31, 2024 42.19K sh
Shares Diluted Q2 2025 · Mar 31, 2024 42.14K sh
Capex Q2 2025 · Mar 31, 2025 $5.29M
Capex Q2 2025 · Mar 31, 2024 $2.76M
Operating Cash Flow Q2 2025 · Mar 31, 2025 $18.25M
Operating Cash Flow Q2 2025 · Mar 31, 2024 $14.9M
Long Term Debt Q2 2025 · Mar 31, 2025 $71.48M
Cash And Equivalents Q2 2025 · Mar 31, 2025 $17.15M
Cash And Equivalents Q2 2025 · Sep 30, 2024 $16.17M
Stockholders Equity Q2 2025 · Mar 31, 2025 $103.57M
Stockholders Equity Q2 2025 · Dec 31, 2024 $106.31M
Stockholders Equity Q2 2025 · Sep 30, 2024 $107.19M
Stockholders Equity Q2 2025 · Mar 31, 2024 $110.35M
Stockholders Equity Q2 2025 · Dec 31, 2023 $110.6M
Stockholders Equity Q2 2025 · Sep 30, 2023 $111.12M
Current Liabilities Q2 2025 · Mar 31, 2025 $61.34M
Current Liabilities Q2 2025 · Sep 30, 2024 $60.85M
Total Liabilities Q2 2025 · Mar 31, 2025 $141.08M
Total Liabilities Q2 2025 · Sep 30, 2024 $140.06M
Current Assets Q2 2025 · Mar 31, 2025 $74.97M
Current Assets Q2 2025 · Sep 30, 2024 $73.05M
Total Assets Q2 2025 · Mar 31, 2025 $244.65M
Total Assets Q2 2025 · Sep 30, 2024 $247.25M
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.07
Eps Diluted Q2 2025 · Mar 31, 2025 −$0.10
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.02
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.05
Eps Basic Q2 2025 · Mar 31, 2025 −$0.07
Eps Basic Q2 2025 · Mar 31, 2025 −$0.10
Eps Basic Q2 2025 · Mar 31, 2024 −$0.02
Eps Basic Q2 2025 · Mar 31, 2024 −$0.05
Net Income Q2 2025 · Mar 31, 2025 −$3.04M
Net Income Q2 2025 · Mar 31, 2025 −$4.13M
Net Income Q2 2025 · Dec 31, 2024 −$1.08M
Net Income Q2 2025 · Mar 31, 2024 −$739K
Net Income Q2 2025 · Mar 31, 2024 −$2.23M
Net Income Q2 2025 · Dec 31, 2023 −$1.49M
Operating Income Q2 2025 · Mar 31, 2025 −$999K
Operating Income Q2 2025 · Mar 31, 2025 −$550K
Operating Income Q2 2025 · Mar 31, 2024 $901K
Operating Income Q2 2025 · Mar 31, 2024 $1.98M
Cost Of Revenue Q2 2025 · Mar 31, 2025 $15.14M
Cost Of Revenue Q2 2025 · Mar 31, 2025 $32.9M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $16.67M
Cost Of Revenue Q2 2025 · Mar 31, 2024 $34.57M
Revenue Q2 2025 · Mar 31, 2025 $33.35M
Revenue Q2 2025 · Mar 31, 2025 $70.41M
Revenue Q2 2025 · Mar 31, 2024 $36.6M
Revenue Q2 2025 · Mar 31, 2024 $74.55M